Therapeutic Advances in Chronic Disease

Papers
(The H4-Index of Therapeutic Advances in Chronic Disease is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Neurological manifestations of long-COVID syndrome: a narrative review117
Nomenclature and clinical phenotypes of atopic dermatitis42
A narrative review of current evidence supporting the implementation of electronic patient-reported outcome measures in the management of chronic diseases28
Dual inhibition of IL-17A and IL-17F in psoriatic disease27
The neurological symptoms of COVID-19: a systematic overview of systematic reviews, comparison with other neurological conditions and implications for healthcare services26
New perspectives on the treatment of hidradenitis suppurativa24
Serum-derived exosomes containing NEAT1 promote the occurrence of rheumatoid arthritis through regulation of miR-144-3p/ROCK2 axis23
MicroRNA-21 from bone marrow mesenchymal stem cell-derived extracellular vesicles targets TET1 to suppress KLF4 and alleviate rheumatoid arthritis23
Impact of previous biologic use and body weight on the effectiveness of guselkumab in moderate-to-severe plaque psoriasis: a real-world practice22
Characteristics and outcomes of patients with chronic thromboembolic pulmonary hypertension in the era of modern therapeutic approaches: data from the Polish multicenter registry (BNP-PL)21
Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease21
Effects of non-invasive brain stimulation in multiple sclerosis: systematic review and meta-analysis19
Melatonin restores osteoporosis-impaired osteogenic potential of bone marrow mesenchymal stem cells and alleviates bone loss through the HGF/PTEN/Wnt/β-catenin axis19
Effect of sodium-glucose cotransporter-2 (SGLT2) inhibitors on serum urate levels in patients with and without diabetes: a systematic review and meta-regression of 43 randomized controlled trials18
Steatosis grading consistency between controlled attenuation parameter and MRI-PDFF in monitoring metabolic associated fatty liver disease18
The interaction and pathogenesis between cognitive impairment and common cardiovascular diseases in the elderly18
Long-chain omega-3 polyunsaturated fatty acids and the risk of heart failure17
Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges17
0.045179843902588